Literature DB >> 18401418

BCR/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress.

M Koptyra, K Cramer, A Slupianek, C Richardson, T Skorski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18401418      PMCID： PMC3857962          DOI： 10.1038/leu.2008.78

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  25 in total

1.  Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins.

Authors:  Nicola Brady; Terry J Gaymes; Manyee Cheung; Ghulam J Mufti; Feyruz V Rassool
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

2.  Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability.

Authors:  Christine Richardson; Jeremy M Stark; Melissa Ommundsen; Maria Jasin
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

Review 3.  Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

Authors:  Bertil Johansson; Thoas Fioretos; Felix Mitelman
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

4.  A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.

Authors:  Ajeeta B Dash; Ifor R Williams; Jeffery L Kutok; Michael H Tomasson; Ema Anastasiadou; Kathleen Lindahl; Shaoguang Li; Richard A Van Etten; Julian Borrow; David Housman; Brian Druker; D Gary Gilliland
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

5.  Silencing expression of the catalytic subunit of DNA-dependent protein kinase by small interfering RNA sensitizes human cells for radiation-induced chromosome damage, cell killing, and mutation.

Authors:  Yuanlin Peng; Qinming Zhang; Hatsumi Nagasawa; Ryuichi Okayasu; Howard L Liber; Joel S Bedford
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  BCR-ABL down-regulates the DNA repair protein DNA-PKcs.

Authors:  E Deutsch; A Dugray; B AbdulKarim; E Marangoni; L Maggiorella; S Vaganay; R M'Kacher; S D Rasy; F Eschwege; W Vainchenker; A G Turhan; J Bourhis
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

7.  Characterization of the translocation breakpoint sequences in Philadelphia-positive acute lymphoblastic leukemia.

Authors:  P C Papadopoulos; A M Greenstein; R A Gaffney; C A Westbrook; L M Wiedemann
Journal:  Genes Chromosomes Cancer       Date:  1990-01       Impact factor: 5.006

8.  Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer.

Authors:  Terry J Gaymes; Ghulam J Mufti; Feyruz V Rassool
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

9.  Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

Authors:  Elias Jabbour; Hagop M Kantarjian; Lynne V Abruzzo; Susan O'Brien; Guillermo Garcia-Manero; Srdan Verstovsek; Jianqin Shan; Mary Beth Rios; Jorge Cortes
Journal:  Blood       Date:  2007-07-11       Impact factor: 22.113

10.  Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.

Authors:  K Mitani; S Ogawa; T Tanaka; H Miyoshi; M Kurokawa; H Mano; Y Yazaki; M Ohki; H Hirai
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598
View more
  35 in total

1.  BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells.

Authors:  Mirle Schemionek; Christian Elling; Ulrich Steidl; Nicole Bäumer; Ashley Hamilton; Tilmann Spieker; Joachim R Göthert; Martin Stehling; Amy Wagers; Claudia S Huettner; Daniel G Tenen; Lara Tickenbrock; Wolfgang E Berdel; Hubert Serve; Tessa L Holyoake; Carsten Müller-Tidow; Steffen Koschmieder
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

2.  Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop.

Authors:  Tariq I Mughal; Jerald P Radich; Richard A Van Etten; Alfonso Quintás-Cardama; Tomasz Skorski; Farhad Ravandi; Daniel J DeAngelo; Carlo Gambacorti-Passerini; Giovanni Martinelli; Ayalew Tefferi
Journal:  Am J Hematol       Date:  2011-09       Impact factor: 10.047

3.  Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia.

Authors:  Daniel W Thomson; Nur Hezrin Shahrin; Paul P S Wang; Carol Wadham; Naranie Shanmuganathan; Hamish S Scott; Marcel E Dinger; Timothy P Hughes; Andreas W Schreiber; Susan Branford
Journal:  Leukemia       Date:  2020-02-19       Impact factor: 11.528

Review 4.  Oncogenes in cell survival and cell death.

Authors:  Jake Shortt; Ricky W Johnstone
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-12-01       Impact factor: 10.005

Review 5.  BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia.

Authors:  B A Burke; M Carroll
Journal:  Leukemia       Date:  2010-05-06       Impact factor: 11.528

Review 6.  Chronic myeloid leukemia: mechanisms of blastic transformation.

Authors:  Danilo Perrotti; Catriona Jamieson; John Goldman; Tomasz Skorski
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

7.  A multicellular basis for the origination of blast crisis in chronic myeloid leukemia.

Authors:  Rainer K Sachs; Kerstin Johnsson; Philip Hahnfeldt; Janet Luo; Allen Chen; Lynn Hlatky
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

Review 8.  Targeting chronic myeloid leukemia stem cells.

Authors:  G Vignir Helgason; Graham A R Young; Tessa L Holyoake
Journal:  Curr Hematol Malig Rep       Date:  2010-04       Impact factor: 3.952

9.  BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability.

Authors:  A Slupianek; R Falinski; P Znojek; T Stoklosa; S Flis; V Doneddu; D Pytel; E Synowiec; J Blasiak; A Bellacosa; T Skorski
Journal:  Leukemia       Date:  2012-10-09       Impact factor: 11.528

10.  Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.

Authors:  Elisabeth P Nacheva; Diana Brazma; Anna Virgili; Julie Howard-Reeves; Anastasios Chanalaris; Katya Gancheva; Margarita Apostolova; Mikel Valgañon; Helen Mazzullo; Colin Grace
Journal:  BMC Genomics       Date:  2010-01-18       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.